An insight into the anticancer potential of sulfonated styrylquinazolines as multifunctional agents targeting microtubules.

Key Points

• Sulfonated styrylquinazolines demonstrate significant anticancer activity against various tumors.
• In preclinical models, these agents show effective targeting of microtubules with potential therapeutic benefits.
• The analysis focuses on molecular targeting mechanisms and their implications for cancer treatment.
• Further validation is needed to explore these agents' efficacy in clinical settings and ensure safety.